BDNF and early-onset autosomal dominant Alzheimer disease: The benefit of PTZ on memory and neuronal plasticity together with its potential neuroprotective effect via BDNF may also argue in favor of considering GABAA antagonist therapy for neurological disorders associating memory deficit to neurodegeneration such as Alzheimer’s disease.